Affini-T Therapeutics Revenue
Biotechnology Research • 
Watertown, Massachusetts, United States • 21-50 Employees
Affini-T Therapeutics revenue & valuation
| Annual revenue | $1,000,000 |
| Revenue per employee | $40,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,200,000 |
| Total funding | $175,000,000 |
Key Contacts at Affini-T Therapeutics
Christopher Klebanoff
Scientific Co-Founder
Ankit Gupta
Senior Sr. Director, Head Of Gene Editing And Program Lead For Afnt-212
Daniel Faga
Board Director
Tomasz Sewastianik
Associate Director, Translational Medicine Leader
Johnny Garcia
Sr. Director Of Quality
Josh Francis
Senior Director, Tcr Discovery
Xingyue He
Senior Director
Soumit Basu
Senior Medical Director
Donovan Farris
Director Of Manufacturing
Company overview
| Headquarters | 100 Forge Rd, Watertown, Massachusetts 02472, US |
| Phone number | +104242025 |
| Website | |
| NAICS | 541714 |
| Employees | 21-50 |
| Socials |
Affini-T Therapeutics Email Formats
Affini-T Therapeutics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@affinittx.com), used 58.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@affinittx.com | 58.3% |
{first name}.{last name} | john.doe@affinittx.com | 37.5% |
{first initial}{last name} | jdoe@affinittx.com | 4.2% |
About Affini-T Therapeutics
Affini-T is a leading clinical stage precision immunotherapy company targeting oncogenic driver mutations, beginning with KRAS, to develop potentially curative therapies for patients with solid tumors. We are advancing two distinct T Cell Receptor (TCR) based therapeutic modalities encompassing adoptive cellular therapies and bispecific T Cell Engagers, each designed to harness T cell immunity with unprecedented precision and potency against solid tumors. Our most advanced TCR T-cell therapies are built based on state-of-the-art engineering, synthetic biology, and gene editing proprietary platforms overcoming the challenges of addressing solid tumors. Our T Cell therapies have high specificity and the multi-faceted ability to strike and persist within the solid tumors. Building on the world-class innovation inherent in our leadership team, founders and differentiating technologies, we are powered to develop transformational medicines that last.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Affini-T Therapeutics has 14 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore Affini-T Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Affini-T Therapeutics Tech Stack
Discover the technologies and tools that power Affini-T Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
JavaScript libraries
JavaScript libraries
Webmail
Programming languages
Blogs
Page builders
SEO
Analytics
UI frameworks
Hosting
Denmark
Poland
United KingdomFrequently asked questions
4.8
40,000 users
